Reviews
Average rating: 5/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 5.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
Remdesivir is the first-line antiviral treatment for hospitalized patients with COVID-19 who are not yet on mechanical ventilation. Administered intravenously over 5 days, it works by inhibiting viral replication and has been shown to shorten recovery time in clinical trials. It is most effective when initiated within 7 days of symptom onset. While generally well tolerated, patients may experience side effects such as nausea or elevated liver enzymes.
0